Top 3 Picks
Score
Score
Score
Complete Rankings
| Rank | Stock | Score | Trend | Price | Market Cap |
|---|---|---|---|---|---|
|
1
|
ECO
Industrials
Okeanis Eco Tankers Corp.
EPS surging >500% YoY, revenue up 239.4%, outperforming the S&P 500 by 29.7 pts over the last 50 sessions, backed by a 57% profit margin and 62% return on equity.
|
84.9 | Neutral | $86.25 | $3.40B |
|
2
|
APP
Information Technology
Applovin Corp
EPS growing 76% year-over-year, revenue up 55.5%, outperforming the S&P 500 by 32.5 pts over the last 50 sessions, backed by a 66% profit margin and 210% return on equity.
|
82.8 | Uptrend | $416.35 | $130.40B |
|
3
|
SEZL
Financials
Sezzle Inc.
EPS growing 84% year-over-year, revenue up 42.6%, outperforming the S&P 500 by 27.8 pts over the last 50 sessions, backed by a 31% profit margin and 84% return on equity.
|
78.5 | Uptrend | $164.78 | $5.20B |
|
4
|
BAM
Financials
Brookfield Asset Management Inc
EPS growing 273% year-over-year, revenue up 71.6%, outperforming the S&P 500 by 4.5 pts over the last 50 sessions, backed by a 71% profit margin and 42% return on equity.
|
77.4 | Uptrend | $50.63 | $82.10B |
|
5
|
AVGO
Information Technology
Broadcom Inc
EPS growing 215% year-over-year, revenue up 85.5%, backed by a 43% profit margin and 44% return on equity.
|
77.0 | Uptrend | $333.40 | $1.74T |
|
6
|
DHT
Energy
DHT Holdings Inc
EPS surging >500% YoY, revenue up 197.3%, outperforming the S&P 500 by 12.3 pts over the last 50 sessions, backed by a 67% profit margin and 56% return on equity.
|
76.1 | Downtrend | $21.68 | $3.60B |
|
7
|
Aris Mining Corporation
EPS growing 250% year-over-year, revenue up 91.6%, outperforming the S&P 500 by 37.9 pts over the last 50 sessions.
|
75.9 | Neutral | $19.16 | $3.80B |
|
8
|
GKOS
Health Care
Glaukos Corp
EPS surging >500% YoY, revenue up 58.0%, outperforming the S&P 500 by 38.3 pts over the last 50 sessions.
|
75.7 | Uptrend | $243.01 | $14.60B |
|
9
|
Frontline Ltd
EPS surging >500% YoY, revenue up 96.5%, outperforming the S&P 500 by 5.5 pts over the last 50 sessions, backed by a 55% profit margin and 54% return on equity.
|
74.7 | Downtrend | $45.57 | $10.40B |
|
10
|
CDNA
Health Care
CareDx Inc
EPS surging >500% YoY, revenue up 39.3%, outperforming the S&P 500 by 58.3 pts over the last 50 sessions, backed by a 26% profit margin and 33% return on equity.
|
74.6 | Uptrend | $74.64 | $4.10B |
|
11
|
INSW
Energy
International Seaways Inc
EPS growing 386% year-over-year, revenue up 147.2%, outperforming the S&P 500 by 5.0 pts over the last 50 sessions, backed by a 68% profit margin and 49% return on equity.
|
74.4 | Neutral | $102.85 | $5.40B |
|
12
|
Palantir Technologies Inc.
EPS growing 144% year-over-year, revenue up 95.9%, backed by a 50% profit margin and 41% return on equity.
|
74.1 | Downtrend | $162.44 | $413.40B |
|
13
|
Micron Technology Inc
EPS surging >500% YoY, revenue up 379.3%, backed by a 64% profit margin and 88% return on equity.
|
73.0 | Downtrend | $728.65 | $903.40B |
|
14
|
NVDA
Information Technology
NVIDIA Corporation
EPS growing 128% year-over-year, revenue up 105.9%, backed by a 64% profit margin and 117% return on equity.
|
73.0 | Downtrend | $157.13 | $4.01T |
|
15
|
SNDK
Information Technology
Sandisk Corp
EPS surging >500% YoY, revenue up 377.9%, backed by a 67% profit margin and 141% return on equity.
|
73.0 | Downtrend | $817.10 | $133.40B |
|
16
|
Arista Networks
EPS growing 82% year-over-year, revenue up 58.5%, outperforming the S&P 500 by 5.1 pts over the last 50 sessions, backed by a 40% profit margin and 34% return on equity.
|
72.8 | Uptrend | $186.28 | $249.60B |
|
17
|
KNSA
Health Care
Kiniksa Pharmaceuticals Ltd
EPS growing 144% year-over-year, revenue up 58.1%, outperforming the S&P 500 by 21.8 pts over the last 50 sessions, backed by a 12% profit margin and 18% return on equity.
|
72.1 | Uptrend | $95.26 | $7.60B |
|
18
|
YOU
Information Technology
Clear Secure Inc
EPS growing 80% year-over-year, revenue up 27.8%, outperforming the S&P 500 by 30.4 pts over the last 50 sessions, backed by a 16% profit margin and 169% return on equity.
|
71.6 | Uptrend | $56.74 | $8.60B |
|
19
|
CRDO
Information Technology
Credo Technology Group Holding Ltd
EPS growing 97% year-over-year, revenue up 114.7%, backed by a 34% profit margin and 31% return on equity.
|
71.5 | Downtrend | $121.96 | $23.90B |
|
20
|
EQH
Financials
Axa Equitable Holdings Inc
EPS surging >500% YoY, revenue up 172.5%, outperforming the S&P 500 by 6.8 pts over the last 50 sessions, backed by a 12% profit margin and 171% return on equity.
|
71.3 | Uptrend | $55.44 | $14.80B |
|
21
|
Astera Labs, Inc. Common Stock
EPS growing 98% year-over-year, revenue up 153.7%, backed by a 30% profit margin and 28% return on equity.
|
70.2 | Downtrend | $206.32 | $39.80B |
|
22
|
SEI
Energy
Solaris Energy Infrastructure, Inc.
EPS growing 38% year-over-year, revenue up 104.4%, outperforming the S&P 500 by 22.1 pts over the last 50 sessions.
|
70.1 | Neutral | $61.44 | $6.40B |
|
23
|
MPWR
Information Technology
Monolithic Power Systems Inc
EPS growing 47% year-over-year, revenue up 63.1%, outperforming the S&P 500 by 16.6 pts over the last 50 sessions, backed by a 24% profit margin and 24% return on equity.
|
69.3 | Uptrend | $1317.50 | $70.60B |
|
24
|
Advanced Micro Devices Inc
EPS growing 94% year-over-year, revenue up 44.7%, outperforming the S&P 500 by 19.1 pts over the last 50 sessions, backed by a 17% profit margin.
|
69.1 | Neutral | $506.18 | $959.90B |
|
25
|
Nexstar Broadcasting Group Inc
EPS growing 270% year-over-year, revenue up 78.0%, outperforming the S&P 500 by 19.1 pts over the last 50 sessions.
|
68.9 | Uptrend | $207.89 | $6.30B |
|
26
|
AAON
Industrials
AAON Inc
EPS growing 124% year-over-year, revenue up 84.1%, outperforming the S&P 500 by 5.0 pts over the last 50 sessions, backed by 21% return on equity.
|
68.8 | Uptrend | $77.72 | $6.50B |
|
27
|
ALM
▲4
Almonty Industries Inc. Common Shar
Revenue up 497.7%, backed by a 125% profit margin and 38% return on equity.
|
68.4 | Downtrend | $8.22 | $2.20B |
|
28
|
TXN
Information Technology
Texas Instruments Incorporated
EPS growing 77% year-over-year, revenue up 27.7%, outperforming the S&P 500 by 21.7 pts over the last 50 sessions, backed by a 34% profit margin and 40% return on equity.
|
68.3 | Uptrend | $296.86 | $285.50B |
|
29
|
Vericel Corp Ord
EPS growing 170% year-over-year, revenue up 26.5%, outperforming the S&P 500 by 42.8 pts over the last 50 sessions, backed by a 10% profit margin.
|
68.1 | Uptrend | $58.48 | $2.90B |
|
30
|
New Gold Inc
EPS growing 275% year-over-year, revenue up 83.5%, backed by a 20% profit margin and 22% return on equity.
|
68.0 | Downtrend | $9.08 | $8.30B |
|
31
|
RXO Inc.
Revenue up 31.7%, outperforming the S&P 500 by 44.2 pts over the last 50 sessions.
|
67.9 | Neutral | $28.45 | $4.70B |
|
32
|
Southside Bancshares, Inc.
EPS growing 481% year-over-year, revenue up 71.9%, outperforming the S&P 500 by 9.1 pts over the last 50 sessions, backed by a 36% profit margin.
|
67.7 | Uptrend | $34.25 | $1.00B |
|
33
|
VICR
Industrials
Vicor Corporation
EPS growing 111% year-over-year, revenue up 78.5%, backed by a 32% profit margin and 24% return on equity.
|
67.5 | Downtrend | $145.64 | $7.60B |
|
34
|
Digitalbridge Group Inc
EPS surging >500% YoY, revenue up 58.9%, outperforming the S&P 500 by 3.3 pts over the last 50 sessions, backed by a 54% profit margin.
|
67.4 | Neutral | $16.00 | $3.00B |
|
35
|
BBB Foods Inc.
EPS growing 250% year-over-year, revenue up 40.3%, outperforming the S&P 500 by 43.0 pts over the last 50 sessions.
|
67.1 | Uptrend | $68.37 | $8.20B |
|
36
|
CMBT
Energy
CMB.TECH NV
EPS surging >500% YoY, revenue up 81.5%, backed by a 37% profit margin and 30% return on equity.
|
67.1 | Neutral | $16.98 | $5.00B |
|
37
|
ASML Holding NV ADR
EPS growing 136% year-over-year, revenue up 55.2%, backed by a 34% profit margin and 66% return on equity.
|
66.8 | Downtrend | $1426.06 | $568.10B |
|
38
|
Eton Pharmaceuticals Inc
Revenue up 157.9%, outperforming the S&P 500 by 8.8 pts over the last 50 sessions, backed by a 35% profit margin and 91% return on equity.
|
66.8 | Uptrend | $64.75 | $1.80B |
|
39
|
TER
Information Technology
Teradyne Inc
EPS growing 189% year-over-year, revenue up 69.8%, backed by a 28% profit margin and 43% return on equity.
|
66.6 | Downtrend | $233.63 | $41.20B |
|
40
|
SharkNinja, Inc.
EPS growing 80% year-over-year, revenue up 21.2%, outperforming the S&P 500 by 31.3 pts over the last 50 sessions, backed by a 12% profit margin and 30% return on equity.
|
66.5 | Uptrend | $225.10 | $31.00B |
|
41
|
Analog Devices Inc
EPS growing 164% year-over-year, revenue up 39.6%, outperforming the S&P 500 by 13.7 pts over the last 50 sessions, backed by a 30% profit margin.
|
66.4 | Neutral | $387.26 | $198.30B |
|
42
|
STX
Information Technology
Seagate Technology PLC
EPS growing 212% year-over-year, revenue up 61.0%, backed by a 32% profit margin and 259% return on equity.
|
66.2 | Downtrend | $497.84 | $125.10B |
|
43
|
GFI
Materials
Gold Fields Ltd ADR
EPS growing 81% year-over-year, revenue up 78.9%, backed by a 39% profit margin and 59% return on equity.
|
66.1 | Neutral | $35.74 | $31.50B |
|
44
|
Protagonist Therapeutics Inc
EPS growing 351% year-over-year, revenue up 5723.6%, backed by a 62% profit margin and 40% return on equity.
|
66.0 | Neutral | $127.32 | $8.70B |
|
45
|
XERS
Health Care
Xeris Pharmaceuticals Inc
EPS surging >500% YoY, revenue up 44.2%, outperforming the S&P 500 by 96.0 pts over the last 50 sessions.
|
66.0 | Uptrend | $16.71 | $3.00B |
|
46
|
TG Therapeutics Inc
Revenue up 60.7%, outperforming the S&P 500 by 15.8 pts over the last 50 sessions, backed by a 12% profit margin and 18% return on equity.
|
66.0 | Uptrend | $63.48 | $9.80B |
|
47
|
Metropolitan Bank Holding
EPS growing 285% year-over-year, revenue up 70.6%, outperforming the S&P 500 by 7.3 pts over the last 50 sessions, backed by a 32% profit margin.
|
65.6 | Uptrend | $96.05 | $1.20B |
|
48
|
FIGS
Health Care
Figs Inc
EPS growing 100% year-over-year, revenue up 25.7%, outperforming the S&P 500 by 47.1 pts over the last 50 sessions, backed by 17% return on equity.
|
65.5 | Uptrend | $21.71 | $3.80B |
|
49
|
BESIY
EPS growing 315% year-over-year, revenue up 113.5%, backed by a 33% profit margin and 57% return on equity.
|
65.2 | Neutral | $171.53 | $13.30B |
|
50
|
Arcutis Biotherapeutics Inc
Revenue up 45.1%, outperforming the S&P 500 by 21.5 pts over the last 50 sessions.
|
65.0 | Neutral | $27.52 | $3.50B |
Score Breakdown: Top 10
Each stock's composite score (0–100) is the sum of five weighted components. Here is exactly where the top 10 earn their points.
EPS surging >500% YoY, revenue up 239.4%, outperforming the S&P 500 by 29.7 pts over the last 50 sessions, backed by a 57% profit margin and 62% return on equity.
EPS growing 76% year-over-year, revenue up 55.5%, outperforming the S&P 500 by 32.5 pts over the last 50 sessions, backed by a 66% profit margin and 210% return on equity.
EPS growing 84% year-over-year, revenue up 42.6%, outperforming the S&P 500 by 27.8 pts over the last 50 sessions, backed by a 31% profit margin and 84% return on equity.
EPS growing 273% year-over-year, revenue up 71.6%, outperforming the S&P 500 by 4.5 pts over the last 50 sessions, backed by a 71% profit margin and 42% return on equity.
EPS growing 215% year-over-year, revenue up 85.5%, backed by a 43% profit margin and 44% return on equity.
EPS surging >500% YoY, revenue up 197.3%, outperforming the S&P 500 by 12.3 pts over the last 50 sessions, backed by a 67% profit margin and 56% return on equity.
EPS growing 250% year-over-year, revenue up 91.6%, outperforming the S&P 500 by 37.9 pts over the last 50 sessions.
EPS surging >500% YoY, revenue up 58.0%, outperforming the S&P 500 by 38.3 pts over the last 50 sessions.
EPS surging >500% YoY, revenue up 96.5%, outperforming the S&P 500 by 5.5 pts over the last 50 sessions, backed by a 55% profit margin and 54% return on equity.
EPS surging >500% YoY, revenue up 39.3%, outperforming the S&P 500 by 58.3 pts over the last 50 sessions, backed by a 26% profit margin and 33% return on equity.
Methodology
Stocks are ranked by the Tradestie Composite Score, a 0–100 rating built from five weighted components: earnings growth (25%), relative strength vs the S&P 500 (25%), revenue growth (20%), profitability (15%), and quality (15%). Only companies with a market cap above $1 billion are eligible — no ETFs, no micro-caps. The screen runs after every trading day across 2301 qualifying stocks. In our internal backtests, the top-ranked names in this screen have historically outperformed the S&P 500 over the following 30–60 trading days on average; past performance does not guarantee future results. Learn more about our methodology.
See the live track record → — every daily cohort measured against the S&P 500, wins and losses.